RS20050911A - Gaboxadol for treating depression and other affective disorders - Google Patents
Gaboxadol for treating depression and other affective disordersInfo
- Publication number
- RS20050911A RS20050911A YUP-2005/0911A YUP20050911A RS20050911A RS 20050911 A RS20050911 A RS 20050911A YU P20050911 A YUP20050911 A YU P20050911A RS 20050911 A RS20050911 A RS 20050911A
- Authority
- RS
- Serbia
- Prior art keywords
- gaboxadol
- treating depression
- affective disorders
- pharmaceutical composition
- relates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Sadašnji pronalazak se odnosi na upotrebu gaboksadola za pripremanje farmaceutskog sastava za lečenje depresije. Šta više, on se odnosi na upotrebu gaboksadola za pripremanje farmaceutskog sastava koji se ima upotrebiti u kombinaciji sa inhibitorom resorbcije serotonina ili bilo kojim jedinjenjem koje izaziva podizanje nivoa ekstracelularnog serotonina.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200300956 | 2003-06-25 | ||
DKPA200400016 | 2004-01-07 | ||
PCT/DK2004/000459 WO2004112786A2 (en) | 2003-06-25 | 2004-06-25 | Gaboxadol for treating depression and other affective disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
RS20050911A true RS20050911A (en) | 2007-08-03 |
Family
ID=58707228
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YUP-2005/0911A RS20050911A (en) | 2003-06-25 | 2004-06-25 | Gaboxadol for treating depression and other affective disorders |
Country Status (10)
Country | Link |
---|---|
KR (1) | KR20060025192A (sr) |
AR (1) | AR047550A1 (sr) |
CA (2) | CA2692334A1 (sr) |
CL (2) | CL2004001607A1 (sr) |
EA (1) | EA200600101A1 (sr) |
IS (1) | IS8138A (sr) |
ME (2) | ME00030B (sr) |
NO (1) | NO20060229L (sr) |
RS (1) | RS20050911A (sr) |
TW (1) | TW200509918A (sr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3883566A4 (en) | 2018-11-21 | 2022-09-07 | Certego Therapeutics Inc. | GABOXADOL FOR SUICIDE RISK REDUCTION AND RAPID DEPRESSION RELIEF |
US11597726B2 (en) | 2020-05-20 | 2023-03-07 | Certego Therapeutics Inc. | Ring deuterated gaboxadol and its use for the treatment of psychiatric disorders |
-
2004
- 2004-06-15 TW TW093117156A patent/TW200509918A/zh unknown
- 2004-06-23 AR ARP040102200A patent/AR047550A1/es not_active Application Discontinuation
- 2004-06-24 CL CL200401607A patent/CL2004001607A1/es unknown
- 2004-06-25 CA CA2692334A patent/CA2692334A1/en not_active Abandoned
- 2004-06-25 EA EA200600101A patent/EA200600101A1/ru unknown
- 2004-06-25 KR KR1020057024823A patent/KR20060025192A/ko not_active Application Discontinuation
- 2004-06-25 RS YUP-2005/0911A patent/RS20050911A/sr unknown
- 2004-06-25 CA CA002529805A patent/CA2529805A1/en not_active Abandoned
- 2004-06-25 ME MEP-2008-19A patent/ME00030B/me unknown
- 2004-06-25 ME MEP-19/08A patent/MEP1908A/xx unknown
-
2005
- 2005-11-21 IS IS8138A patent/IS8138A/is unknown
-
2006
- 2006-01-16 NO NO20060229A patent/NO20060229L/no not_active Application Discontinuation
-
2010
- 2010-02-25 CL CL2010000166A patent/CL2010000166A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
TW200509918A (en) | 2005-03-16 |
AR047550A1 (es) | 2006-01-25 |
ME00030B (me) | 2010-06-10 |
CL2004001607A1 (es) | 2005-05-27 |
IS8138A (is) | 2005-11-21 |
CA2529805A1 (en) | 2004-12-29 |
KR20060025192A (ko) | 2006-03-20 |
NO20060229L (no) | 2006-01-16 |
CL2010000166A1 (es) | 2010-07-02 |
CA2692334A1 (en) | 2004-12-29 |
MEP1908A (xx) | 2010-02-10 |
EA200600101A1 (ru) | 2006-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL202106A0 (en) | Gaboxadol for treating depression and other affective disorders | |
TW201713640A (en) | Bruton's tyrosine kinase inhibitors | |
TN2010000122A1 (en) | Compounds and compositions as modulators of gpr119 activity | |
PL2134704T3 (pl) | Związki i kompozycje pełniące rolę modulatorów aktywności GPR119 | |
CL2008003407A1 (es) | Compuestos derivados de aril- y heteroarilcarbonilo de heterobiciclo sustituido; composicion farmaceutica; procedimiento de preparacion; y su uso en el tratamiento y/o prevencion de trastornos metabolicos, mediado por la inhibicion de la enzima hsd-1. | |
MX2007010560A (es) | Roflumilast para el tratamiento de diabetes mellitus. | |
MX2009000657A (es) | Composiciones y metodos para el tratamiento de mucositis. | |
MX2009010960A (es) | Compuestos heterociclicos y sus metodos de uso. | |
TW200745122A (en) | New compounds I | |
MA32776B1 (fr) | Inhibiteurs de l'akt et de la p70 s6 kinase | |
MX340807B (es) | Nuevas composiciones para prevenir y/o tratar trastornos degenerativos del sistema nervioso central. | |
CL2008003231A1 (es) | Compuestos derivados de 1,3-dihidro-5-isobenzofurancarbonitrilo sustituido, inhibidores selectivos de la recaptacion de serotonina; composicion farmaceutica; procedimiento de preparacion; utiles en el tratamiento y/o prevencion de la eyaculacion prematura. | |
MX2007006042A (es) | Bengamidas que poseen un ciclo caprolactama sustituido, procedimiento de preparacion, composiciones que las contienen y utilizacion. | |
TW200716153A (en) | Mitotic kinesin inhibitors and methods of use thereof | |
TW200745133A (en) | New compounds II | |
MY142082A (en) | Substituted pyrroles, compositions containing them, method of manufacture and use | |
MX2009013126A (es) | Nuevos compuestos 892. | |
UA90656C2 (ru) | Габоксадол для лечения депрессии | |
RS20050911A (en) | Gaboxadol for treating depression and other affective disorders | |
WO2009158387A3 (en) | Compositions, formulations, and methods for preventing and/or treating physical effects of alcohol consumption | |
WO2007121883A3 (de) | 1,4:3,6-dianhydromannitol-derivate und deren verwendung | |
TW200603791A (en) | Compounds and compositions as cathepsin S inhibitors | |
CL2009001113A1 (es) | Compuestos derivados de 4,5-diarilpirrol-2-carboxamida; procedimiento de preparacion de estos; composicion farmaceutica que los comprende; uso en el tratamiento y/o prevencion de trastornos psiquiatricos, dependencia a sustancias, entre otras. | |
WO2009105218A3 (en) | Propiophenone derivatives | |
MXPA06013945A (es) | Piperidinas sustituidas, novedosas, como moduladores de la neurotransmision de dopamina. |